Deprescribing for Dementia
(R2D2 Trial)
Trial Summary
What is the purpose of this trial?
A cluster-randomized controlled trial (RCT) called "Reducing Risk of Dementia through Deprescribing" (R2D2) to evaluate the impact of a deprescribing intervention on important cognitive and safety outcomes.
Will I have to stop taking my current medications?
The trial focuses on reducing the use of certain anticholinergic medications, so you may need to stop or reduce these specific drugs. The protocol does not specify if you must stop other medications.
What data supports the effectiveness of deprescribing anticholinergic medications for dementia?
Research suggests that reducing anticholinergic medications in dementia patients can be beneficial, as a high anticholinergic burden is linked to worse treatment outcomes, increased delirium, and higher mortality rates. Deprescribing these medications may help improve cognitive function and reduce the risk of adverse effects.12345
Is deprescribing anticholinergic medications safe for people with dementia?
Deprescribing anticholinergic medications, which are often used in older adults with dementia, can be safe and may help reduce the risk of further cognitive decline or neuropsychiatric issues. Reducing the use of these medications can lower the 'anticholinergic burden' (the combined effect of all anticholinergic medications a person takes), which is linked to adverse effects.14678
How is the deprescribing of anticholinergic drugs unique for dementia treatment?
Deprescribing anticholinergic drugs for dementia is unique because it focuses on reducing the overall anticholinergic burden, which may help minimize cognitive decline and neuropsychiatric symptoms, unlike other treatments that add medications. This approach is different from standard treatments that often involve prescribing additional drugs, potentially leading to a prescribing cascade.1491011
Eligibility Criteria
This trial is for people aged 65 or older who have seen their primary care doctor in the past year, are currently using certain anticholinergic medications known to affect memory, can speak English, and have a phone. It's not for those living in nursing homes or with schizophrenia, bipolar disorder, Alzheimer's Disease or related dementias.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Deprescribing of target anticholinergics (Other)
- Usual Care (Other)